Market Cap 9.83M
Revenue (ttm) 3.00M
Net Income (ttm) 39.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 1,326.33%
Debt to Equity Ratio 0.00
Volume 101,700
Avg Vol 172,638
Day's Range N/A - N/A
Shares Out 17.09M
Stochastic %K 74%
Beta 1.06
Analysts Strong Sell
Price Target $11.50

Company Profile

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precance...

Industry: Medical Devices
Sector: Healthcare
Phone: (917) 813-1828
Address:
360 Madison Avenue, 25th Floor, New York, United States
Carter113
Carter113 Jul. 16 at 11:52 PM
$LUCD $PAVM A lot of room for upside price target revisions once the draft LCD is published!!!
2 · Reply
quegoalasoche
quegoalasoche Jul. 16 at 10:29 PM
$PAVM eft rebalance.... L u c i d.
0 · Reply
mahaljs
mahaljs Jul. 16 at 5:57 PM
0 · Reply
LPlates
LPlates Jul. 16 at 5:38 PM
$LUCD $PAVM This is interesting to see such a CONTORTIONIST at work. This was literally days ago. Today's post from you is the COMPLETE opposite. Care to explain? 😞😞 Maybe include one of your posts since the BEGINNING of TIME that hasn't spun ANY and ALL setbacks as "good news" I will wait for that. What's that I hear? 🦗 🦗 🦗 CRICKETS
2 · Reply
Carter113
Carter113 Jul. 16 at 4:55 PM
$LUCD $PAVM Today’s announcement is very positive for several reasons. If they were not getting coverage no meeting would have been scheduled. This meeting is to bring all the gov’t contractors together as MolDx has been the only contractor involved thus far. Institutions/investors will be able to listen in and more importantly the transcript of the meeting can/will be used after the Medicare decision with private payers to secure coverage even quicker. The Data is pristine and I believe coverage will be granted soon after the Sept 4th meeting and LUCD will be able to submit for reimbursement for the last 12 months of claims prior to the end of 2025. They have plenty of cash well into Q2 of next year and if the decision on Medicare comes with in 30-45 days after Sept 4th, then they will have approx 12M of reimbursement claims coming in soon which will further extend the run way and utilize the ATM at prices in the $4-6 range. They own a very valuable asset with zero competition
2 · Reply
dmc4321
dmc4321 Jul. 16 at 2:19 AM
$LUCD @Elomee This claims I am wrong. I am not. Please take into account the PAVM MSA plus the minimum cash balance that is required by the covenants that have been waived until December. Choose your start date and explain cash on that date, add the funds raised, subtract the PAVM MSA & Quarterly losses, subtract minimum cash balance according to covenants that have been waived. Couple of other things you should consider is $PAVM and the breech of their covenants. What happens if the investor does NOT continue to waive them? Does one breech TRIGGER all loans? It used to but I have not read the later SEC filings closely. Finally this is a meeting to DISCUSS not to DECIDE. Read the meeting outline. No decisions, just information sharing and a discussion. https://palmettogba.com/jmb/did/kvluxg5ryu So APPROVAL IS BEST CASE 2026. If you dont consider what the INVESTORS who now CONTROL LUCD want then you will get burnt. Do they want to wait another 2 years and invest more or are they looking for an EXIT?
0 · Reply
Carter113
Carter113 Jul. 16 at 12:26 AM
$LUCD $PAVM https://www.wishtv.com/news/health-spotlight/health-spotlight-new-test-offers-early-detection-of-esophageal-cancer/?fbclid=PAQ0xDSwLj0OFleHRuA2FlbQIxMQABpyyhjFOkEfUbdOKSZi7L4n0MI2ZMqVFYO_MC8Sh4tPvjnexMBq3vDatx17Y1_aem_-jE_jg7GgigVO3Vb-znl9Q
0 · Reply
Thegame7000
Thegame7000 Jul. 15 at 2:05 PM
$PAVM today is the day
0 · Reply
BigJuicy
BigJuicy Jul. 14 at 5:13 PM
$PAVM the struggle is real… I don’t think management plans to be delisted but let’s see how this plays out
0 · Reply
Thegame7000
Thegame7000 Jul. 14 at 4:40 PM
0 · Reply
Latest News on PAVM
PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript

May 15, 2025, 1:58 PM EDT - 2 months ago

PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript


PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 11:08 AM EDT - 4 months ago

PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript


PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 3:49 PM EST - 8 months ago

PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript


Carter113
Carter113 Jul. 16 at 11:52 PM
$LUCD $PAVM A lot of room for upside price target revisions once the draft LCD is published!!!
2 · Reply
quegoalasoche
quegoalasoche Jul. 16 at 10:29 PM
$PAVM eft rebalance.... L u c i d.
0 · Reply
mahaljs
mahaljs Jul. 16 at 5:57 PM
0 · Reply
LPlates
LPlates Jul. 16 at 5:38 PM
$LUCD $PAVM This is interesting to see such a CONTORTIONIST at work. This was literally days ago. Today's post from you is the COMPLETE opposite. Care to explain? 😞😞 Maybe include one of your posts since the BEGINNING of TIME that hasn't spun ANY and ALL setbacks as "good news" I will wait for that. What's that I hear? 🦗 🦗 🦗 CRICKETS
2 · Reply
Carter113
Carter113 Jul. 16 at 4:55 PM
$LUCD $PAVM Today’s announcement is very positive for several reasons. If they were not getting coverage no meeting would have been scheduled. This meeting is to bring all the gov’t contractors together as MolDx has been the only contractor involved thus far. Institutions/investors will be able to listen in and more importantly the transcript of the meeting can/will be used after the Medicare decision with private payers to secure coverage even quicker. The Data is pristine and I believe coverage will be granted soon after the Sept 4th meeting and LUCD will be able to submit for reimbursement for the last 12 months of claims prior to the end of 2025. They have plenty of cash well into Q2 of next year and if the decision on Medicare comes with in 30-45 days after Sept 4th, then they will have approx 12M of reimbursement claims coming in soon which will further extend the run way and utilize the ATM at prices in the $4-6 range. They own a very valuable asset with zero competition
2 · Reply
dmc4321
dmc4321 Jul. 16 at 2:19 AM
$LUCD @Elomee This claims I am wrong. I am not. Please take into account the PAVM MSA plus the minimum cash balance that is required by the covenants that have been waived until December. Choose your start date and explain cash on that date, add the funds raised, subtract the PAVM MSA & Quarterly losses, subtract minimum cash balance according to covenants that have been waived. Couple of other things you should consider is $PAVM and the breech of their covenants. What happens if the investor does NOT continue to waive them? Does one breech TRIGGER all loans? It used to but I have not read the later SEC filings closely. Finally this is a meeting to DISCUSS not to DECIDE. Read the meeting outline. No decisions, just information sharing and a discussion. https://palmettogba.com/jmb/did/kvluxg5ryu So APPROVAL IS BEST CASE 2026. If you dont consider what the INVESTORS who now CONTROL LUCD want then you will get burnt. Do they want to wait another 2 years and invest more or are they looking for an EXIT?
0 · Reply
Carter113
Carter113 Jul. 16 at 12:26 AM
$LUCD $PAVM https://www.wishtv.com/news/health-spotlight/health-spotlight-new-test-offers-early-detection-of-esophageal-cancer/?fbclid=PAQ0xDSwLj0OFleHRuA2FlbQIxMQABpyyhjFOkEfUbdOKSZi7L4n0MI2ZMqVFYO_MC8Sh4tPvjnexMBq3vDatx17Y1_aem_-jE_jg7GgigVO3Vb-znl9Q
0 · Reply
Thegame7000
Thegame7000 Jul. 15 at 2:05 PM
$PAVM today is the day
0 · Reply
BigJuicy
BigJuicy Jul. 14 at 5:13 PM
$PAVM the struggle is real… I don’t think management plans to be delisted but let’s see how this plays out
0 · Reply
Thegame7000
Thegame7000 Jul. 14 at 4:40 PM
0 · Reply
dmc4321
dmc4321 Jul. 14 at 3:56 AM
Normally I ignore you but ..... you brought up Ayrton That is why IMO you have to be very naieve to discount what might happen if a lender decides that what the company wants / needs is NOT what the investor wants. Ayrton was bought out. Now we dont know why? But it is VERY relevant IMO. It shows that Ayrton in dealing with another company with an SPA like $PAVM $LUCD had was sued by Genius entertainement as a predatory lender. So that shows that in one example one of the lenders who Lishan said MULTIPLE times was supportive etc and waived covenants at the exact same time tried to ENFORCE THEM with a very similair SPA. Ayrton folded immediately and gave up the $200M they were owed. But Ayrton demanded it and were legally entitled to it per the SPA. It was Ayrtons desire not to go through discovery and what that might find that forced them IMO to give up $200M. Its all in the public record. So here is a direct example of a lender trying to destroy a company and wipe out retail.
1 · Reply
xx007xx
xx007xx Jul. 12 at 2:21 PM
$LUCD $PAVM 😂 defending the other handle
2 · Reply
Carter113
Carter113 Jul. 11 at 2:11 PM
$LUCD $PAVM Expecting to hear that a new draft LCD has been published with the change from “non-covered” to “covered” in the coming weeks to days. From that point the stock won’t look back as the reimbursment will be aligned with the technology and the fact that there is no competition to combat this growing cancer! They own an extremely valuable asset when these 2 are aligned!
1 · Reply
TheTonyDean
TheTonyDean Jul. 10 at 9:08 PM
$PAVM imminent ? My ass.
0 · Reply
trout290zzaam
trout290zzaam Jul. 10 at 5:05 PM
Anyone want to seriously try to game this out? How in the world does $PAVM survive thru this year to gain back Nasdaq listing requirements if $LUCD doesnt succeed here? What are they gonna do, RS again? They'll never find another investor after that. Any thoughts?
3 · Reply
quegoalasoche
quegoalasoche Jul. 10 at 2:34 PM
$PAVM failure to deliver! FtDssssss
0 · Reply
BigJuicy
BigJuicy Jul. 9 at 2:21 PM
$PAVM below .5 and this goes to .1 I’ll sell at .48 for a loss and move on
0 · Reply
BigJuicy
BigJuicy Jul. 8 at 5:53 PM
$PAVM what is happening to this thing SMH
1 · Reply
BigJuicy
BigJuicy Jul. 8 at 12:56 PM
$PAVM get something done all the employees and no PR ever
0 · Reply
Prizzz
Prizzz Jul. 7 at 9:55 PM
$PAVM Are they even still using Esoguard? Any tests being done...? What an absolute FAILURE Lishan and Pavmed are
0 · Reply
Carter113
Carter113 Jul. 7 at 5:48 PM
$LUCD $PAVM I believe that we see a draft of the new LCD by the end of July if not sooner with the language changed from “non-covered” to “covered”. From there it will be about 90 days and then they will be able to submit all of the back dated claims up to 12 months. LUCD will start to move up on this announcement and will not look back! I would not be surprised if they are starting to ramp up test volume as they know wide coverage is almost upon us! We will know the answer to that and a lot more come the Aug 15th earnings call! Once the new draft LCD is published I believe that LUCD will become a large acquisition target!
2 · Reply
Thegame7000
Thegame7000 Jul. 7 at 3:48 PM
$PAVM me and PAVVY
0 · Reply